Oldest pages

Jump to navigation Jump to search

Showing below up to 37 results in range #371 to #407.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. PUBLIC COMMENT WORK PAGE‏‎ (17:29, 17 January 2024)
  2. Wiki Accounts‏‎ (17:40, 17 January 2024)
  3. About QIBA‏‎ (17:43, 17 January 2024)
  4. Ultrasound SWS Biomarker Ctte‏‎ (19:08, 17 January 2024)
  5. PET Myocardial Blood Flow Biomarker Committee‏‎ (19:11, 17 January 2024)
  6. CT Volumetry Biomarker Ctte‏‎ (19:14, 17 January 2024)
  7. Main Page‏‎ (22:14, 17 January 2024)
  8. Work Product for Review‏‎ (16:56, 19 January 2024)
  9. Public Comment Process‏‎ (16:57, 19 January 2024)
  10. Publication Process‏‎ (17:12, 19 January 2024)
  11. Technical Confirmation Process‏‎ (17:27, 19 January 2024)
  12. Committee Procedures‏‎ (17:32, 19 January 2024)
  13. Selection Process‏‎ (17:36, 19 January 2024)
  14. Review Process‏‎ (17:37, 19 January 2024)
  15. Process‏‎ (19:32, 19 January 2024)
  16. Vetting Requirements‏‎ (19:36, 19 January 2024)
  17. Claim Confirmation Process‏‎ (19:57, 19 January 2024)
  18. Profile Editions‏‎ (20:01, 19 January 2024)
  19. Education‏‎ (22:33, 8 February 2024)
  20. MRE Profile‏‎ (21:17, 24 April 2024)
  21. Volume Blood Flow Call Summaries‏‎ (17:28, 7 May 2024)
  22. CTA, Clinically Feasible Profile‏‎ (20:38, 23 May 2024)
  23. MR DWI of the ADC, Clinically Feasible Profile‏‎ (15:30, 29 May 2024)
  24. MR Elastography of the Liver, Clinically Feasible Profile‏‎ (16:06, 6 June 2024)
  25. Pulse-Echo Quantitative Ultrasound (PEQUS) Call Summaries‏‎ (15:56, 7 June 2024)
  26. FDG-PET/CT SUV for Response to Cancer Therapy, Clinically Feasible Profile‏‎ (17:51, 7 June 2024)
  27. ISMRM/QIBA PDFF Biomarker Ctte‏‎ (13:54, 21 June 2024)
  28. Atherosclerosis Biomarkers by CTA, Clinically Feasible Profile‏‎ (14:55, 11 July 2024)
  29. MRE Biomarker Ctte‏‎ (15:21, 11 July 2024)
  30. CT Angiography Biomarker Ctte‏‎ (15:22, 11 July 2024)
  31. DWI MR Biomarker Ctte‏‎ (15:28, 11 July 2024)
  32. FDG-PET Biomarker Ctte‏‎ (15:32, 11 July 2024)
  33. Atherosclerosis Biomarkers by CTA, Clinically Feasible Profile 2024June‏‎ (15:48, 11 July 2024)
  34. Ultrasound Measurement of Shear Wave Speed for Estimation Liver Fibrosis, Clinically Feasible Profile‏‎ (15:54, 11 July 2024)
  35. Small Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, Clinically Feasible Profile‏‎ (17:42, 11 July 2024)
  36. Profiles‏‎ (18:16, 11 July 2024)
  37. CT Tumor Volume Change for Advanced Disease, Clinically Feasible Profile‏‎ (18:26, 11 July 2024)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)